GlobeNewswire
-
SELLAS Life Sciences Announces Proposed $150.0 Million Underwritten Public Offering
17/11/2026 -
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
17/11/2026 -
Windward Bio to Participate at the Jefferies London Global Healthcare Conference
17/11/2026 -
Amneal Announces European Approval of Adcomfo® (Omalizumab), a Biosimilar to XOLAIR®
17/11/2026 -
Akebia Therapeutic’s Vafseo® (vadadustat) Granted Additional Patent
17/11/2026 -
Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
17/11/2026 -
Mobia Medical to Participate in the Piper Sandler 38th Annual Healthcare Conference
17/11/2026 -
Iridex Reports Third Quarter 2026 Financial Results
17/11/2026 -
Inspire Medical Systems, Inc. to Present at the Piper Sandler 38th Annual Healthcare Conference
17/11/2026 -
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/11/2026 -
PacBio to Participate in the Piper Sandler 38th Annual Healthcare Conference
17/11/2026 -
CVRx to Participate at the Piper Sandler 38th Annual Healthcare Conference
17/11/2026 -
Dazed, Inc. Reports 72.5% Gross Margin and 121% Royalty Growth as Texas Lawmakers File Adult-Use Cannabis Bills in Home Market
17/11/2026 -
Newly Launched CuraeChoice Platform Unlocks Healthcare Pricing Visibility for Nearly 370,000 Employers by Tax ID Alone
17/11/2026 -
Terumo Neuro Announces Publication of RESTORE Registry Results in the Journal of NeuroInterventional Surgery
17/11/2026 -
Davion Healthcare Plc Provides Shareholders with Guidance on Direct Registration and Confirmation of Share Ownership
17/11/2026 -
Nine-month interim report (Q3) 2026 (unaudited)
17/11/2026 -
Medicenna Therapeutics Reports Second Quarter Fiscal 2027 Financial Results and Provides Corporate Update
17/11/2026 -
Firefly Neuroscience Reports 373% Year-Over-Year Increase in U18 ADHD Evoke™ Scans as Commercial Expansion Accelerates
17/11/2026
Pages